Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

SAQ Training Versus Small-Sided Games for Cardiovascular Adaptations in Youth Football Players (SAQ-SSG)

3. juni 2026 oppdatert av: Sarah Kotb Banawi, Benha University

Comparative Effects of Speed, Agility, and Quickness Training and Small-Sided Games on Cardiovascular Response in Youth Football Players: A Randomized Controlled Trial

This randomized controlled trial aimed to compare the effects of Speed, Agility, and Quickness (SAQ) training and Small-Sided Games (SSGs) on cardiovascular adaptations in youth football players. Thirty-six male youth football players were randomly assigned to an SAQ training group and an SSG group. Participants completed an 8-week intervention program. Cardiovascular outcomes, including resting heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure, were assessed before and after the intervention. The study evaluated the effectiveness of these training approaches for improving cardiovascular health and physiological adaptations in youth football players.

Studieoversikt

Detaljert beskrivelse

Football training methods may induce different physiological and cardiovascular adaptations in youth athletes. Speed, Agility, and Quickness (SAQ) training is widely used to enhance neuromuscular performance, while Small-Sided Games (SSGs) provide sport-specific training stimuli that combine technical, tactical, and physical demands.

The purpose of this randomized controlled trial was to compare the effects of SAQ training and SSGs on cardiovascular responses in youth football players. Thirty-six male football players aged 14-16 years were randomly allocated to one of three groups: an SAQ training group, an SSG group, or a control group. The intervention lasted 8 weeks.

Cardiovascular measurements included resting heart rate, systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Assessments were conducted before and after the intervention period. The study investigated whether SAQ training and SSGs produce different cardiovascular adaptations and whether either intervention is superior to regular football training for improving cardiovascular health indicators in youth football players.

This study was conducted in accordance with institutional ethical approval and informed consent procedures.

Studietype

Intervensjonell

Registrering (Faktiske)

18

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Qalyubia Governorate
      • Banhā, Qalyubia Governorate, Egypt, 13111
        • Benha Sporting Club

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Barn

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

Male football players aged 14 to 16 years. Minimum of 2 years of organized football training experience. Regular participation in football training at least 3 times per week. Ability to participate in all training sessions and assessments. Written informed consent provided by participants and their parents or legal guardians.

Exclusion Criteria:

Musculoskeletal injury within the previous 3 months. History of cardiovascular disease. Metabolic disorders. Neurological disorders. Use of medications that could affect cardiovascular responses or physical performance.

Failure to complete the intervention or assessment procedures.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: SAQ Training Group
Participants received the SAQ training intervention for 8 weeks
Participants completed an 8-week Speed, Agility, and Quickness (SAQ) training program designed to improve movement efficiency, agility, acceleration, and cardiovascular adaptations. Training sessions were integrated into the regular football training schedule and were performed throughout the intervention period
Eksperimentell: Small-Sided Games Group
Participants received the Small-Sided Games training intervention for 8 weeks
Participants completed an 8-week Small-Sided Games (SSG) training program involving soccer-specific game-based exercises performed in reduced playing areas. The intervention was designed to provide technical, tactical, and physiological training stimuli and to promote cardiovascular adaptations.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Resting Heart Rate
Tidsramme: Baseline and Week 8
Resting heart rate measured in beats per minute (bpm)
Baseline and Week 8
Exercise Heart Rate
Tidsramme: Baseline and Week 8
Heart rate measured immediately after completion of the 20-meter shuttle run test.
Baseline and Week 8
Resting Diastolic Blood Pressure
Tidsramme: Baseline and Week 8
Resting diastolic blood pressure measured in mmHg.
Baseline and Week 8
Resting Systolic Blood Pressure
Tidsramme: Baseline and Week 8
Resting systolic blood pressure measured in mmHg.
Baseline and Week 8

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

2. mars 2026

Primær fullføring (Faktiske)

27. april 2026

Studiet fullført (Faktiske)

27. april 2026

Datoer for studieregistrering

Først innsendt

3. juni 2026

Først innsendt som oppfylte QC-kriteriene

3. juni 2026

Først lagt ut (Faktiske)

8. juni 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

8. juni 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • REF:3/26

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere